Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00705601 · ClinicalTrials.gov registry record
Nonrestorative Sleep RSQ (Restorative Sleep Questionnaire) Development-- Methodology Study
A clinical trial, sponsored by Pfizer.
- Terminated
- Registry status
- 64
- Enrollment target
NCT00705601: Clinical Trial study, sponsored by Pfizer.
NCT00705601 is a clinical trial that was terminated before completion, run by Pfizer. The registered enrollment target is 64 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00705601 was terminated before completion, sponsored by Pfizer.
- TERMINATED
- Registry status
- 64 participants
- Enrollment target
Study Summary
To begin to refine development of the RSQ (Restorative Sleep Questionnaire) measure in subjects with NRS (Nonrestorative Sleep) by generating item content pertaining to morning refreshment and uncovering problems in instrument administration in subjects with nonrestorative sleep
Interventions
- PROCEDURE PSG
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2008-08 |
| Est. Completion | 2009-01 |
Why NCT00705601 stopped before completion
NCT00705601 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 64 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which PSG is the first listed.
NCT00705601 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00705601 about?
NCT00705601 is a clinical study titled "Nonrestorative Sleep RSQ (Restorative Sleep Questionnaire) Development-- Methodology Study". To begin to refine development of the RSQ (Restorative Sleep Questionnaire) measure in subjects with NRS (Nonrestorative Sleep) by generating item content pertaining to morning refreshment and uncovering problems in instrument administration in subjects with nonrestorative sleep
What is the current status of trial NCT00705601?
This trial is currently terminated. The enrollment target is 64 participants. The study started on 2008-08. Estimated completion is 2009-01.
What interventions are being tested in trial NCT00705601?
The interventions under investigation include: PSG (PROCEDURE).
Who is sponsoring clinical trial NCT00705601?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia